Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine
acetylcholine receptor
acetylcholine receptor antibody
acetylcholinesterase
activities of daily living
advance directives
advances in neurology
adverse drug reaction
age associated memory impairment
aggression
agitation
algorithm
alpha methyltyrosine
Alzheimer's disease
Alzheimer's disease, behavioral symptoms
Alzheimer's disease, diagnosis of
Alzheimer's disease, driving with
Alzheimer's disease, early symptoms
Alzheimer's disease, familial
Alzheimer's disease, pathogenesis
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treating associated medical problems in
Alzheimer's disease, treatment of
amantadine
amitriptyline
amnesia
amphetamines
amyloid beta protein
amyloid imaging
analgesic
anesthesia, general
anesthesia, local
anorexia
antibiotics
antibiotics, neurologic complications with
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antioxidant
antistriational muscle antibody
anxiety
apnea
apolipoprotein E
apomorphine
apraxia
apraxia, constructional
arthralgia
arthrogryposis multiplex
ataxia
ataxia, hereditary
atropine
atypical
autoimmune disease
autonomic dysfunction
azathioprine
baclofen
behavior
behavior, combative
behavioral disorder
Bell's phenomenon
benzodiazepine
beta adrenergic blocker
biological warfare
blepharospasm
Brueghel's syndrome
bulbar palsy
caloric testing
caloric testing, unconscious patient
camphor
carbamazepine
caregiver
CAT scan, emission
CAT scan, emission, abnormal
cerebellar atrophy, primary
cerebrospinal fluid, elevated protein of
chemical weapons
chlorambucil
choline chloride
cholinergic crisis
cholinergic drug
chorea
chronic fatigue syndrome
clonazepam
clozapine
clubfoot as related to neurologic disease
cocaine
cognition
Collier's sign
coma
complications
conflict of interest
confusion
congenital myasthenic syndromes
consanguinity
contrast agents, neurotoxicity of
controversies in neurology
cost
cost effectiveness
critical care unit
cyclophosphamide
cyclosporine
cytokines
deanol
DEET
delay in diagnosis
delirium
delusion
dementia
dementia, cerebrovascular disease causing
dementia, diagnostic classification
dementia, diagnostic evaluation of
dementia, prevention of
dementia, treatment of
dementia, unknown etiology
deprenyl
depression
developmental retardation
diarrhea
differential diagnosis
dilantin
diplopia
donepezil
dopamine
dopamine agonist
dopamine antagonist
driving
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug interactions
drug overdose
drug withdrawal
dysnomia
dystonia
dystonia, drug induced
dystonia, face
dystonic reaction, acute
eating disorder
echolalia
efficacy
electroconvulsive therapy
electromyogram
electromyogram, decremental response
emergencies, neurologic
enzyme inhibition
ephedrine
ergonovine
evidence-based research
executive dysfunction
exercise
exome sequencing
eye closure
eye, pain in
facial hallucinations
facial weakness
falling
fatigue
felbamate
folic acid
Friedreich's ataxia
galantamine
gammaglobulin therapy, intravenous
gene
gene mutation
genetic neurologic disorders
Gilles de la Tourette syndrome
ginkgo biloba
ginseng
Gulf War syndrome
hallucination
haloperidol
headache
hepatitis
heralding manifestation
herbs
high arched palate
hoarding
Huntington's chorea
hyperbaric oxygen
hyperbaric treatment
iatrogenic neurologic disorders
immunologic disease
immunosuppressive agents
inappropriate behavior
insect repellent
insecticides
insomnia
intellectual deficit
interferon
intestinal pseudoobstruction
irritability
lacrimation
lecithin
level of consciousness, decreased
Lewy body disease, diffuse
lid abnormalities
lid closure, weakness of
lid twitch
lidocaine
lithium
liver disease
liver function enzymes
malabsorption
malformation, CNS, congenital
managed care
maprotiline
mediastinum, mass of
memantine
memory
memory, defect of recent
memory, disorder, treatment of
memory, impairment of
memory, impairment of, subjective
mestinon
metrifonate
microcephaly
mild cognitive impairment
Mini Mental Status Examination
miosis
misdiagnosis
mongolism
mortality
movement disorder
movement disorder, drug induced
MRI, abnormal
multiple sclerosis
muscle biopsy
muscle pain
muscle weakness
muscle weakness, proximal
myasthenia gravis
myasthenia gravis, anticholinesterase malabsorption in
myasthenia gravis, anticholinesterase serum levels in
myasthenia gravis, classification
myasthenia gravis, diagnosis
myasthenia gravis, differential diagnosis
myasthenia gravis, drug induced
myasthenia gravis, etiology of
myasthenia gravis, infantile and juvenile
myasthenia gravis, misdiagnosis of
myasthenia gravis, neuromuscular junction in
myasthenia gravis, ocular
myasthenia gravis, presenting manifestations
myasthenia gravis, prognosis of
myasthenia gravis, receptor site in
myasthenia gravis, remission of
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, unmasked
myasthenic crisis
mycophenolate
nalidixic acid
narcotic analgesics
nasal speech
nausea and vomiting
nerve agents
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic consultation
neurologic disease
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuromuscular blockade
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuromuscular junction, abnormality of
neuroophthalmology
neuropathology
neuropathy
neuropathy, toxic
neurotoxic
neurotoxin
NMDA antagonists
nonsteroidal anti-inflammatory drug
nursing home
nystagmus
occupational neurologic disorders
ocular motility, disorders of
oculocephalic reflex
olanzapine
old age, neurology of
opened mouth
ophthalmoplegia
ophthalmoplegia, total
pain, abdominal
papaverine
paranoia
Parkinson disease
Parkinson disease, dementia with
Parkinson disease, nonmotor problems of
Parkinsonism syndrome
patient information and support
penicillamine
penicillin
personality change
phencyclidine poisoning
phenobarbital
phenothiazine
phenylpropanolamine
physostigmine
pimozide
Pisa syndrome
Pittsburgh Compound B
plasmapheresis
poison, neurologic problems with
poison, organophosphate
polyneuropathy
postural abnormality
practice guidelines
pregnancy, neurologic complications in
premarin
prevention of neurologic disorders
prognosis
propranolol
prosopometamorphopsia
prostigmine
pseudointernuclear ophthalmoplegia
psychiatric disorder
psychiatric problems in neurologic disorders
psychological testing
psychomotor retardation
psychosis
psychotic behavior
ptosis
ptosis, bilateral
pupil, dilated, bilateral
quality of life
quetiapine
quinine
radiotracer imaging
repetitive nerve stimulation
repetitive questioning
reserpine and reserpine like drugs
respiratory failure
respiratory paralysis, pharmacologic
review article
Reye's syndrome
rhinorrhea
risk factors
risk-benefit assessment
risperidone
rivastigmine
rummaging
saccadic eye movements
saccadic eye movements, abnormal
safety
salivation, excessive
Sarin
seizure
seizure, drug-induced
selective serotonin reuptake inhibitors
senile plaques
seronegative
serum alanine aminotransferase
shadowing
single photon emission computed tomography
single-fiber electromyography
sleep
sleep pathology and physiology
snake bite
Soman
spinocerebellar ataxia type 1
spinocerebellar degeneration
stereotyped behavior
steroid
steroid therapy, CNS treatment and complications with
sumatriptan
sympathomimetic drugs
Tabun
tachycardia
tachypnea
tardive dyskinesia
tardive dyskinesia, treatment of
tensilon
tensilon test, false negative
tensilon test, false positive
tensilon test, paradoxical
tetrabenazine
tetrahydroaminoacridine
thymectomy
thymoma
thymus and neuromuscular function
toxins, nervous system
treatment of neurologic disorder
treatment, non-pharmacologic
upgaze, paralysis of
vaccination, neurologic complications with
visuospatial disturbance
vitamin E
vitamin K
voice, abnormality of
VX
wandering
war
weakness
weakness, fatiguable
weakness, generalized
weakness, proximal
weight loss
white matter disease
workup
Showing articles 800 to 850 of 871 << Previous Next >>

Tardive Dyskinesia
BMJ 296:150-151, Barnes,T.R.E., 1988

Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988

Nosocomial Aseptic Meningitis Associated with Administration of OKT3
JAMA 259:2002-2005, Martin,M.A.,et al, 1988

Understanding Diabetic Neuropathy
NEJM 319:577-578, Asbury,A.K., 1988

Regeneration & Repair of Myelinated Fibers in Sural-Nerve Biopsy in Pts with Diabetic Neuropathy Treated with Sorbinil
NEJM 319:548-555, Sima,A.A.F.,et al, 1988

Nerve Glucose, Fructose, Sorbitol, Myo-Inositol, and Fiber Degeneration & Regeneration in Diabetic Neuropathy
NEJM 319:542-548, Dyck,P.J.,et al, 1988

Phenelzine Toxicity Responsive to Dantrolene
Neurol 37:865-867, Verrilli,M.R.,et al, 1987

Vitamin E Deficiency & Neurologic Disease in Adults with Cystic Fibrosis
Ann Int Med 107:51-54, Sitrin,M.D.,et al, 1987

Adult-Onset Spinocerebellar Syndrome with Idiopathic Vitamin E Deficiency
Ann Neurol 22:84-87, Yokota,T.,et al, 1987

Lack of Tocopherol in Peripheral Nerves of Vitamin E-Deficient Patients with Peripheral Neuropathy
NEJM 317:262-265, Traber,M.G.,et al, 1987

Acetazolamide-Responsive Myotonia Congenita
Neurol 37:488-491, Trudell,R.G.,et al, 1987

Update on Parkinson Disease
NY State J Med, 87:147-1531987., Lieberman,A.N., 1987

Peripheral Neuropathy Associated with Monoclonal IgM Autoantibody
Ann Neurol 22:764-767, Steck,A.J.,et al, 1987

The Spectrium of Neurologic Disorder From Vitamin E Deficiency
Neurol 36:917-921, Satya-Murti,S.,et al, 1986

Electrophysiologic Features of Abetalipoproteinemia:Functional Consequences of Vitamin E Deficiency
Neurol 36:669-673, Brin,M.F.,et al, 1986

Immunologic Responses of Progressive Multiple Sclerosis Patients Treated with an Anti-T-Cell Monoclonal Antibody
Neurol 36:777-784, Hafler,D.A.,et al, 1986

MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986

Vitamin E Deficiency Associated with Vision Loss & Bulbar Weakness
Ann Neurol 18:725-727, Larsen,P.D.,et al, 1985

Cerebrospinal Fluid Acetylcholinesterase Activity in Senile Dementia of the Alzheimer Type
Ann Neurol 17:46-48, Tune,L.,et al, 1985

Improved Neurologic Function After Long-Term Correction of Vitamin E Deficiency in Children with Chronic Cholestasis
NEJM 313:1580-1586, Sokol,R.J.,et al, 1985

Diagnostic Importance of Immunological Markers in Lymphoma Involving the Central Nervous System
Ann Neurol 16:668-672, Ezrin-Waters,C.,et al, 1984

Response Variations in the Treatment of Parkinson's Disease
Neurol 34:1507-1509, deJong,G.J.,et al, 1984

Use of Monoclonal Antibody Panel to Identify Malignant Cells in Cerebrospinal Fluid
Lancet 1:1095-1098, Coakham,H.B.,et al, 1984

Pyridoxine Deficiency & Peripheral Neuropathy Associated with Long-Term Phenelzine Therapy
Am J Med 75:887-888, Heller,C.A.,et al, 1983

Vitamin E & Neurological Function
Lancet 1:225-228, Muller,D.P.R.,et al, 1983

Aldose Reductase Inhibition Improves Nerve Conduction Velocity In Diabetic Patients
NEJM 308:119-125, Judzewitsch,R.G.,et al, 1983

Protective Effect of Vitamin E (DL-Alpha-Tocopherol) Against Intraventricular Haemorrhage in Premature Babies
BMJ 287:81-84, Chiswick,M.L.,et al, 1983

Acetazolamide-Responsive Episodic Ataxia Syndrome
Neurol 33:1212-1214, Zasorin,N.L.,et al, 1983

Chronic Inflammatory Polyradiculoneuropathy Complicated by Factor VIII Antibody
Neurol 33:1224-1226, Berger,J.R.,et al, 1983

Central Sleep Apnea, Improvement With Acetazolamide Therapy
Arch Int Med 142:1816-1819, White,D.P.,et al, 1982

Spinocerebellar Degeneration Secondary to Chronic Intestinal Malabsorption:A Vitamin E Deficiency Syndrome
Ann Neurol 12:419-424, Harding,A.E.,et al, 1982

Deprenyl In Parkinson's Disease
Lancet 2:695-696, , 1982

Acute Effects of Acetazolamide in Hyperkalemic Periodic Paralysis
Neurol 31:725-729, Riggs,J.E.,et al, 1981

Deprenyl in Parkinson Disease
Neurol 31:19-23, Eisler,T.,et al, 1981

Association Of Spinocerebellar Disorders With Cystic Fibrosis Or Chronic Childhood Cholestasis & Very Low Serum Vit. E
Lancet 2:1319-1321, Elias,E.,et al, 1981

Vitamin E Deficiency in Werdnig-Hoffmann Disease
Ann Neurol 10:266-268, Shapira,Y.,et al, 1981

Increased Dosage of Carbidopa in Patients with Parkinson's Disease Receiving Low Doses of Levodopa
Arch Neurol 37:146-149, Hoehn,M.M., 1980

Increased Ratio of Carbidopa to Levodopa in Treatment of Parkinson's Disease
Arch Neurol 37:723-726, Tourtellotte,W.W.,et al, 1980

Sinemet-25/100
Medical Letter, 22:511980., , 1980

Acquired Hemophilia, Meningioma, & Diphenyl-hydantoin Therapy
J Neurosurg 53:600-605, O'Reilly,R.A.,et al, 1980

Abetalipoproteinemia, Report of Two Cases & Review of Therapy
Arch Neurol 37:659-662, Illingworth,D.R.,et al, 1980

Acetazolamide-Induced Improvement in Hydro-cephalus
Arch Neurol 37:376, Donat,J.F., 1980

Proximal Myopathy after Prolonged Total Therapeutic Starvation
BMJ 280:1212-1213, Scobie,I.N.,et al, 1980

Familial Periodic Ataxia
Arch Neurol 36:568-569, Donat,J.R.,et al, 1979

Reversibility of Human Myopathy Caused by Vitamin E Deficiency
Neurol 29:1182-1186, Tomasi,L.G., 1979

Comparative Effectiveness of Two Extracerebral DOPA Decarboxylase Inhibitors in Parkinson Disease
Neurol 28:964-968, Lieberman,A.,et al, 1978

Hereditary Paroxysmal Ataxia:Response to Acetazolamide
Neurol 28:1259-1264, Griggs,R.C.,et al, 1978

Effects of Acetazolamide on Myotonia
Ann Neurol 3:531, Griggs,R.C.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Clinical Syndromes of Myasthenia in Infancy & Childhood
Arch Neurol 35:97, Fenichel,G.M., 1978



Showing articles 800 to 850 of 871 << Previous Next >>